Insider · CIK 0001207789
SCHOEMAKER KATHLEEN K
Reports to the SEC for 31 companies · PRINCETON, NJ
Transactions
50
Companies
31
Filings
3
CIK
0001207789
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2014-03-19 | CADENCE PHARMACEUTICALS INCD Disposition to Issuer | −$41.6M |
| 2014-03-19 | CADENCE PHARMACEUTICALS INCD Disposition to Issuer | −$710K |
| 2014-03-19 | CADENCE PHARMACEUTICALS INCD Disposition to Issuer | −$102M |
| 2014-03-19 | CADENCE PHARMACEUTICALS INCD Disposition to Issuer | −$1.1M |
| 2014-03-19 | CADENCE PHARMACEUTICALS INCD Disposition to Issuer | −$385K |
| 2014-03-17 | Achaogen, Inc.C Conversion | — |
| 2014-03-17 | Achaogen, Inc.C Conversion | — |
| 2014-03-17 | Achaogen, Inc.Series B Preferred StockC Conversion | — |
| 2014-03-17 | Achaogen, Inc.Series C Preferred StockC Conversion | — |
| 2014-03-17 | Achaogen, Inc.Series D Preferred StockC Conversion | — |
| 2014-03-17 | Achaogen, Inc.Series B Preferred StockC Conversion | — |
| 2014-03-17 | Achaogen, Inc.Series C Preferred StockC Conversion | — |
| 2014-03-17 | Achaogen, Inc.Series D Preferred StockC Conversion | — |
| 2014-02-04 | Dicerna Pharmaceuticals IncC Conversion | — |
| 2014-02-04 | Dicerna Pharmaceuticals IncC Conversion | — |
| 2014-02-04 | Dicerna Pharmaceuticals IncSeries B Preferred StockC Conversion | — |
| 2014-02-04 | Dicerna Pharmaceuticals IncSeries C Preferred StockC Conversion | — |
| 2014-02-04 | Dicerna Pharmaceuticals IncWarrantC Conversion | — |
| 2014-02-04 | Dicerna Pharmaceuticals IncWarrantC Conversion | — |
| 2014-02-04 | Dicerna Pharmaceuticals IncSeries B Preferred StockC Conversion | — |
| 2014-02-04 | Dicerna Pharmaceuticals IncSeries C Preferred StockC Conversion | — |
| 2014-02-04 | Dicerna Pharmaceuticals IncWarrantC Conversion | — |
| 2014-02-04 | Dicerna Pharmaceuticals IncWarrantC Conversion | — |
| 2013-11-19 | TNDMTANDEM DIABETES CARE INCC Conversion | — |
| 2013-11-19 | TNDMTANDEM DIABETES CARE INCC Conversion | — |
| 2013-11-19 | TNDMTANDEM DIABETES CARE INC · Series B Preferred StockC Conversion | — |
| 2013-11-19 | TNDMTANDEM DIABETES CARE INC · Series C Preferred StockC Conversion | — |
| 2013-11-19 | TNDMTANDEM DIABETES CARE INC · Series D Preferred StockC Conversion | — |
| 2013-11-19 | TNDMTANDEM DIABETES CARE INC · Warrant to Purchase Series D Preferred StockJ Other | — |
| 2013-11-19 | TNDMTANDEM DIABETES CARE INC · Warrant to Purchase Common StockJ Other | — |
| 2013-11-19 | TNDMTANDEM DIABETES CARE INC · Series B Preferred StockC Conversion | — |
| 2013-11-19 | TNDMTANDEM DIABETES CARE INC · Series C Preferred StockC Conversion | — |
| 2013-11-19 | TNDMTANDEM DIABETES CARE INC · Series D Preferred StockC Conversion | — |
| 2013-11-19 | TNDMTANDEM DIABETES CARE INC · Warrant to Purchase Series D Preferred StockJ Other | — |
| 2013-11-19 | TNDMTANDEM DIABETES CARE INC · Warrant to Purchase Common StockJ Other | — |
| 2013-11-04 | VCYTVERACYTE, INC.C Conversion | — |
| 2013-11-04 | VCYTVERACYTE, INC.C Conversion | — |
| 2013-11-04 | VCYTVERACYTE, INC. · Series B Preferred StockC Conversion | — |
| 2013-11-04 | VCYTVERACYTE, INC. · Series B Preferred StockC Conversion | — |
| 2013-11-04 | VCYTVERACYTE, INC. · Series C Preferred StockC Conversion | — |
| 2013-11-04 | VCYTVERACYTE, INC. · Series C Preferred StockC Conversion | — |
| 2013-09-30 | EVOKEvoke Pharma IncC Conversion | — |
| 2013-09-30 | EVOKEvoke Pharma IncC Conversion | — |
| 2013-09-30 | EVOKEvoke Pharma Inc · Series A Preferred StockC Conversion | — |
| 2013-09-30 | EVOKEvoke Pharma Inc · Series A Preferred StockC Conversion | — |
| 2013-08-27 | Tobira Therapeutics, Inc.C Conversion | — |
| 2013-08-27 | Tobira Therapeutics, Inc.C Conversion | — |
| 2013-08-27 | Tobira Therapeutics, Inc.C Conversion | — |
| 2013-08-27 | Tobira Therapeutics, Inc.C Conversion | — |
| 2013-08-27 | Tobira Therapeutics, Inc.P Purchase | +$3M |
Recent filings
- 4CADENCE PHARMACEUTICALS INC0000904454-14-000321SEC(opens sec.gov)
- 4Achaogen Inc0000904454-14-000299SEC(opens sec.gov)
- 4Dicerna Pharmaceuticals Inc0000904454-14-000131SEC(opens sec.gov)
Companies
- Achaogen, Inc.10% Owner
- ACHILLION PHARMACEUTICALS INC10% Owner
- ALIMERA SCIENCES INC10% Owner
- Atara Biotherapeutics, Inc.10% OwnerATRA
- aTYR PHARMA INC10% OwnerATYR
- CADENCE PHARMACEUTICALS INC10% Owner
- Celator Pharmaceuticals Inc10% Owner
- Clovis Oncology, Inc.10% Owner
- CoLucid Pharmaceuticals, Inc.10% Owner
- Dicerna Pharmaceuticals Inc10% Owner
- Durata Therapeutics, Inc.10% Owner
- Esperion Therapeutics, Inc.10% OwnerESPR
- Evofem Biosciences, Inc.10% OwnerEVFM
- Evoke Pharma Inc10% OwnerEVOK
- GLAUKOS Corp10% OwnerGKOS
- MARINUS PHARMACEUTICALS, INC.10% Owner
- Northstar Neuroscience, Inc.10% Owner
- Ocera Therapeutics, Inc.10% Owner
- Orexigen Therapeutics, Inc.10% Owner
- OTONOMY, INC.10% Owner
- Paratek Pharmaceuticals, Inc.10% Owner
- Pernix Sleep, Inc.10% Owner
- REVA Medical, Inc.10% Owner
- SANTARUS INC10% Owner
- SENOMYX INC10% Owner
- TANDEM DIABETES CARE INC10% OwnerTNDM
- Tobira Therapeutics, Inc.10% Owner
- Vanda Pharmaceuticals Inc.10% OwnerVNDA
- VERACYTE, INC.10% OwnerVCYT
- Volcano Corp10% Owner
- ZOGENIX, INC.10% Owner
Address
C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE
PRINCETON, NJ, 08542